丹麦慢性血栓栓塞性肺动脉高压伴或不伴静脉血栓栓塞症病史的发病率与临床病程
基于丹麦全国患者登记系统2009至2018年数据,共识别509例慢性血栓栓塞性肺动脉高压(CTEPH)患者,其中82%有静脉血栓栓塞症(VTE)病史。研究期间CTEPH年发病率为0.5至0.8/10万人年。有VTE病史者VTE发生率为2571/10万人年,无VTE病史者为980/10万人年;有VTE病史者出血事件发生率为5008/10万人年,无VTE病史者为7139/10万人年。有VTE病史者5年生存率为65%(95%CI 58%-71%),无VTE病史者为45%(95%CI 31%-58%)。
要点
- 丹麦2009至2018年CTEPH年发病率为0.5至0.8/10万人年,与其他欧洲国家相当。
- 有VTE病史的CTEPH患者VTE发生率为2571/10万人年,无VTE病史者为980/10万人年。
- 有VTE病史者5年生存率65%(95%CI 58%-71%),无VTE病史者45%(95%CI 31%-58%)。
核心结论
- 丹麦CTEPH发病率与其他欧洲国家相当。
- 有与无VTE病史的CTEPH患者在预后方面存在显著差异。
- 这些发现可能支持生成关于CTEPH病理生理学的假设,并为当前患者护理提供信息。
研究设计与样本
- 利用覆盖丹麦所有医院的丹麦国家患者登记系统,基于CTEPH的ICD-10编码及相关诊断和/或治疗操作的出院诊断组合,识别2009至2018年间所有CTEPH病例。
- 共识别509例CTEPH患者,其中82%有VTE病史。
- 计算CTEPH每10万人年的发病率、VTE和出血事件发生率以及5年生存率估计。
主要发现
- 研究期间CTEPH年发病率为0.5至0.8/10万人年。
- 有VTE病史者VTE发生率为2571/10万人年,无VTE病史者为980/10万人年。
- 有VTE病史者出血事件发生率为5008/10万人年,无VTE病史者为7139/10万人年。
- 有VTE病史者5年生存率为65%(95%CI 58%-71%),无VTE病史者为45%(95%CI 31%-58%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A considerable number of patients with chronic thromboembolic pulmonary hypertension (CTEPH) lack a history of venous thromboembolism (VTE). OBJECTIVES: We aimed to examine the annual incidence and prevalence of CTEPH in Denmark and to compare the rates of VTE, bleeding, and mortality between CTEPH patients with and without a history of VTE. METHODS: The Danish National Patient Registry covering all Danish hospitals was used to identify all CTEPH cases between 2009 and 2018, based on combinations of discharge diagnoses using International Classification of Diseases, 10th Revision codes for CTEPH and relevant diagnostic and/or therapeutic interventions. Incidence rates of CTEPH per 100 000 person-years, rates of VTE and bleeding, and 5-year survival estimates were calculated. RESULTS: In total, 509 CTEPH patients were identified, of whom 82% had a history of VTE. The yearly incidence rate of CTEPH was 0.5 to 0.8 per 100 000 person-years during the study period. Patients with a history of VTE experienced a 2.5-fold rate of VTE compared with those without prior VTE (2571 vs 980 per 100 000 person-years), while the rate of bleeding events was lower (5008 vs 7139 per 100 000 person-years). The 5-year survival of CTEPH patients with a VTE history was 65% (95% CI, 58%-71%) compared with 45% (95% CI, 31%-58%) in patients without a history of VTE. CONCLUSION: The Danish incidence rate of CTEPH was comparable with that of other European countries. We identified notable differences in the prognosis of patients with CTEPH with or without a history of VTE. These findings may support generation of hypotheses regarding the pathophysiology of CTEPH and inform current patient care.
引用
- Klok FA, Vágó E, Horváth-Puhó E, et al. Incidence and clinical course of chronic thromboembolic pulmonary hypertension with or without a history of venous thromboembolism in Denmark. J Thromb Haemost. 2024. PMID: 39306096. doi:10.1016/j.jtha.2024.09.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。